Capital Investment Advisory Services, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 83 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital Investment Advisory Services, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$7,000
-36.4%
8980.0%0.00%
-33.3%
Q2 2019$11,000
+120.0%
8980.0%0.00%
+50.0%
Q1 2019$5,000
+400.0%
898
+125.6%
0.00%
Q4 2018$1,0003980.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders